Literature DB >> 2109730

Ek alpha transgene in B10 mice suppresses the development of myasthenia gravis.

P Christadoss1, C S David, M Shenoy, S Keve.   

Abstract

Mice bearing the H-2b haplotype are susceptible to the development of experimental autoimmune myasthenia gravis (EAMG), induced by acetylcholine receptor (AChR) autoimmunity. One of the genes influencing EAMG susceptibility has been mapped to the Ab locus of the major histocompatibility complex, and the A beta chain has been implicated in the pathogenesis. Mice of the H-2b haplotype, including C57BL/10 (B10), have a genomic deletion of the E alpha gene and therefore fail to express the E molecule on their cell surface. To test the hypothesis that failure to express the cell surface E molecule in B10 mice contributes to EAMG pathogenesis, Ek alpha transgenic B10 mice expressing the E molecule were examined. Expression of the E molecule in Ek alpha transgenic B10 mice partially prevented the development of EAMG.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109730     DOI: 10.1007/bf00204895

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  22 in total

Review 1.  Immunogenetics of experimental autoimmune myasthenia gravis.

Authors:  P Christadoss
Journal:  Crit Rev Immunol       Date:  1989       Impact factor: 2.214

2.  C5 gene influences the development of murine myasthenia gravis.

Authors:  P Christadoss
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

3.  Genetic control of experimental autoimmune myasthenia gravis in mice. I. Lymphocyte proliferative response to acetylcholine receptors is under H-2-linked Ir gene control.

Authors:  P Christadoss; V A Lennon; C David
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

4.  Correcting an immune-response deficiency by creating E alpha gene transgenic mice.

Authors:  M Le Meur; P Gerlinger; C Benoist; D Mathis
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

5.  HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis.

Authors:  J Säfwenberg; L Hammarström; J B Lindblom; G Matell; E Möller; P O Osterman; C I Smith
Journal:  Tissue Antigens       Date:  1978-08

6.  Genetic control of autoimmunity to acetylcholine receptors: role of Ia molecules.

Authors:  P Christadoss; V A Lennon; C J Krco; E H Lambert; C S David
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

7.  HLA-DQ beta-chain polymorphism linked to myasthenia gravis.

Authors:  J Bell; L Rassenti; S Smoot; K Smith; C Newby; R Hohlfeld; K Toyka; H McDevitt; L Steinman
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

8.  Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.

Authors:  P Christadoss; J M Lindstrom; N Talal; C R Duvic; A Kalantri; M Shenoy
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

9.  H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway.

Authors:  C N Baxevanis; N Ishii; Z A Nagy; J Klein
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

10.  Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.

Authors:  P W Berman; J Patrick
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  7 in total

1.  Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.

Authors:  Yi-chi M Kong; Nicholas K Brown; Jeffrey C Flynn; Daniel J McCormick; Vladimir Brusic; Gerald P Morris; Chella S David
Journal:  J Autoimmun       Date:  2011-06-17       Impact factor: 7.094

2.  Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Authors:  Huan Yang; Elzbieta Goluszko; Chella David; David K Okita; Bianca Conti-Fine; Teh-sheng Chan; Mathilde A Poussin; Premkumar Christadoss
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

3.  H2E-derived Ealpha52-68 peptide presented by H2Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis.

Authors:  Nicholas K Brown; Daniel J McCormick; Chella S David; Yi-chi M Kong
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

4.  A novel H2A-E+ transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes.

Authors:  Nicholas K Brown; Daniel J McCormick; Vladimir Brusic; Chella S David; Yi-Chi M Kong
Journal:  Cell Immunol       Date:  2008-04-14       Impact factor: 4.868

Review 5.  Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.

Authors:  Yi-Chi M Kong; Gerald P Morris; Nicholas K Brown; Yan Yan; Jeffrey C Flynn; Chella S David
Journal:  J Autoimmun       Date:  2009-10-12       Impact factor: 7.094

6.  Both positive and negative effects on immune responses by expression of a second class II MHC molecule.

Authors:  Peggy P Ni; Yaming Wang; Paul M Allen
Journal:  Mol Immunol       Date:  2014-07-10       Impact factor: 4.407

7.  Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis.

Authors:  M A Gonzalez-Gay; G H Nabozny; M J Bull; E Zanelli; J Douhan; M M Griffiths; L H Glimcher; H S Luthra; C S David
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.